HQ

EQS-News: Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB

Retrieved on: 
Wednesday, April 10, 2024
EUR, Holding company, Supervisory board, Frankfurt Stock Exchange, Acquisition, SDAX, Goods, Regulated market, MUX, HQ, Porcelain

Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB

Key Points: 
  • Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB
    The issuer is solely responsible for the content of this announcement.
  • Third acquisition in 2024: Mutares has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB
    Munich, April 10, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement to acquire Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. from Eltel AB.
  • In business since 1961 and 1949 respectively, Eltel Networks Energetyka S.A. and Eltel Networks Engineering S.A. are among the leading providers of electrical power engineering services in Poland with revenues of approx.
  • Robin Laik, CEO of Mutares, comments: "With the acquisition of Eltel Networks Energetyka and Eltel Networks Engineering, we are signing our first transaction in Poland strengthening our Goods & Services segment in the field of electrical power engineering & construction services.

EQS-News: Second acquisition in 2024: Mutares has signed an agreement for the transfer of Magirus from Iveco Group

Retrieved on: 
Wednesday, April 10, 2024
EXM, EUR, Growth, Supervisory board, Frankfurt Stock Exchange, Iveco, CFO, Acquisition, SDAX, Goods, IVG, Airport, Regulated market, MUX, HQ

Munich, March 13, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement for the transfer of Magirus from Iveco Group (EXM: IVG).

Key Points: 
  • Munich, March 13, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has signed an agreement for the transfer of Magirus from Iveco Group (EXM: IVG).
  • Due to the required unbundling measures, the transaction is expected to be completed no later than January 2025.
  • Mark Friedrich, CFO of Mutares, comments on the transaction: “Magirus is a typical Mutares acquisition where the company stands for a reputed brand with high quality and represents a compelling value proposition.
  • As the portfolio grows, so do consulting revenues, which together with portfolio dividends and exit proceeds accrue to the Mutares Holding.

EQS-News: Mutares with successful fiscal year 2023: Net income of Mutares Holding increases to EUR 102.5 million – dividend of EUR 2.25 per share planned

Retrieved on: 
Wednesday, April 10, 2024
Annual, Tax, Holding company, Growth, Supervisory board, Frankfurt Stock Exchange, Policy, Acquisition, Sale, SDAX, SMP, Investment, Annual report, Mutares, Mobility, Depreciation, Regulated market, MUX, Service, HQ, Film industry

Mutares with successful fiscal year 2023: Net income of Mutares Holding increases to EUR 102.5 million – dividend of EUR 2.25 per share planned

Key Points: 
  • Mutares with successful fiscal year 2023: Net income of Mutares Holding increases to EUR 102.5 million – dividend of EUR 2.25 per share planned
    The issuer is solely responsible for the content of this announcement.
  • The net income of Mutares Holding for the fiscal year 2023 increased to EUR 102.5 million, compared with EUR 72.9 million in the previous year.
  • The Mutares Group generated revenues of EUR 4,689.1 million in the fiscal year 2023 (previous year: EUR 3,751.7 million).
  • Accordingly, net income in the Holding Company is expected to be in the range of EUR 125 million to EUR 150 million for the fiscal year 2025 and EUR 200 million for the fiscal year 2028.

New Report Shares Trends, Insights, and Actions to Shift Power

Retrieved on: 
Thursday, April 4, 2024
Equitable, ERA, Culture, Organization, Environment, International non-governmental organization, Partnership, Perception, Policy, Thought, Civil society, Traction, DEIB, HQ, Management

“ Operationalizing Locally-Led Development: Cultivating a Healthy Global Development Ecosystem ” also includes findings from Humentum’s second annual Equitable, Resilient, Accountable (ERA) 2023 Index .

Key Points: 
  • “ Operationalizing Locally-Led Development: Cultivating a Healthy Global Development Ecosystem ” also includes findings from Humentum’s second annual Equitable, Resilient, Accountable (ERA) 2023 Index .
  • The report also includes specific recommendations for how to make progress in each area:
    Trends: Changing partnership policies and frameworks.
  • Anticipated Actions: Testing new approaches, with multiple options gaining traction but no “one way” surfacing.
  • Anticipated Actions: More examination of culture, as leaders realize the key role it plays in living out organizational policies and values.

MIPS Continues To Expand With The Addition Of Industry Leaders from NVIDIA, Google and SiFive

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Semiconductor, Automotive, Other Automotive, Technology, Networks, Hardware, Freedom, Conference, Intel, Communication, Computer, Samsung Electronics, Software, Senior, Texas Instruments, IP, SiFive, Software engineering, Motorola, Manav, NVIDIA, Automotive industry, Data, HQ

“I am joining the MIPS team at a critical time when the company, AI-compute and RISC-V adoption are growing tremendously,” said Srivasatava.

Key Points: 
  • “I am joining the MIPS team at a critical time when the company, AI-compute and RISC-V adoption are growing tremendously,” said Srivasatava.
  • Additionally, Mr. Mediratta will also serve as the site manager and leader of MIPS’ Software Center of Excellence located in Bengaluru.
  • Prior to SiFive, Mr. Ullah held technical and product management roles for companies including Samsung Electronics, Freescale-NXP and Motorola.
  • If you would like to learn more about MIPS, please visit the company’s website at https://mips.com/ .

Good Inside & Out: GoodPop Partners with Good Deeds Day for National Day of Service

Retrieved on: 
Tuesday, April 9, 2024
Olive, Friends, Snack, Patient, Saffron Road, Dog, BFAS, Tree, MTV Global, LOVE, Partnership, Seed, Uncommon Goods, Food, Woman, City, Duck pond, HQ, Earth Day, Organization, McDonald House, Hunger, Bed, Volunteering, Vegetable, Research, Anxiety, Cancer, Student, RSVP, Pet, Family, GoodPop, Movement, Good Deeds, Element, Pearl Street Mall, HEB, Collection, Blood, Zappos, Tourism

AUSTIN, Texas, April 9, 2024 /PRNewswire/ -- GoodPop®, the leading maker of cleaned-up classic treats, continues its partnership with Good Deeds Day, the annual global movement encouraging good deeds. This year, GoodPop will again head up efforts in 15+ cities to further expand the movement across the United States.

Key Points: 
  • AUSTIN, Texas, April 9, 2024 /PRNewswire/ -- GoodPop® , the leading maker of cleaned-up classic treats, continues its partnership with Good Deeds Day , the annual global movement encouraging good deeds.
  • GoodPop, a certified B Corp, focuses on doing good through elements like sourcing, philanthropy, and nutrition education.
  • We can't think of a better partner to lead Good Deeds Day across the US and make the world brighter, one small act at a time"
    Good Deeds Day events in the U.S. include:
    Austin, Texas — GoodPop is bringing Good Deeds Day Fest to the Austin community!
  • RSVP here
    Austin, Texas — The Central Texas Food Bank will be hosting a canned food drive at GoodPop's Good Deeds Day Fest!

VEON 4Q23 trading update: Strong organic growth in revenue and EBITDA, solid execution of VEON 2.0 strategy

Retrieved on: 
Thursday, March 21, 2024
VEON, Growth, Health, FY, Education, Capital expenditure, Yoy, Euronext Amsterdam, USD, HQ, Total, LTM, Cryptocurrency

In 4Q23, VEON continued to report growth in revenues in reported currency terms with double digit local currency top-line growth.

Key Points: 
  • In 4Q23, VEON continued to report growth in revenues in reported currency terms with double digit local currency top-line growth.
  • Total revenues reached USD 953 million, an increase of 1.4% YoY in reported currency (+17.9% YoY in local currency normalised for one-offs).
  • VEON has announced its full-year revenue guidance of 16-18% growth in local currency, EBITDA guidance of 18%-20% growth, and outlook for the Group’s capex intensity for 2024 year at 18%-19%.
  • We are pleased to guide the market for continued strong and profitable growth in 2024, maintaining our focus on financial discipline and balance sheet management.”

Iveco Group announces an agreement with Mutares to transfer the ownership of MAGIR

Retrieved on: 
Wednesday, March 13, 2024
Magirus, EXM, ASTRA, Iveco, Agriculture, IDV, FPT Industrial, IVG, IVECO, Mutares, Firefighter, HQ

Iveco Group (EXM: IVG) and Mutares SE & Co. KGaA (ISIN: DE000A2NB650), an investment holding focused on special situations transactions, announced today the signing of a definitive agreement for the transfer of ownership of Magirus GmbH and its affiliates performing firefighting business (“MAGIRUS”).

Key Points: 
  • Iveco Group (EXM: IVG) and Mutares SE & Co. KGaA (ISIN: DE000A2NB650), an investment holding focused on special situations transactions, announced today the signing of a definitive agreement for the transfer of ownership of Magirus GmbH and its affiliates performing firefighting business (“MAGIRUS”).
  • In 2023, MAGIRUS represented approximately 2% of Iveco Group revenues and recorded an Adjusted EBIT loss of €35 million.
  • As a result of this transaction, Iveco Group 2024 results will be negatively impacted by approximately €115 million in the first quarter of 2024.
  • Iveco Group employs more than 35,000 people around the world and has 20 industrial sites and 29 R&D centres.

Charles River to Perform Plasmid Production for Ship of Theseus

Retrieved on: 
Thursday, April 4, 2024
Research, Medical Devices, Genetics, Biotechnology, Health, Pharmaceutical, General Health, Other Science, Science, Diabetes, Neutropenia, CDMO, Psoriasis, Infertility, Cancer, MCB, Tissue, CRL, DNA, Pattern hair loss, HOX, Ship, Acquisition, Factorization of polynomials, Display resolution, GMP, Good manufacturing practice, Tecmar, Therapy, HQ, Vaccine

Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement.
  • Ship of Theseus will leverage Charles River’s premier expertise to manufacture GMP plasmid DNA to serve as the active drug substance for its lead candidate.
  • Charles River’s GMP plasmid DNA CDMO center of excellence based in Keele, United Kingdom will lead the collaboration, providing services that include plasmid DNA backbone generation, plasmid synthesis, GMP master cell bank (MCB) generation, pre-production evaluation, and GMP plasmid DNA manufacture including in-house release testing.
  • We trust the team’s decades of success developing, producing, and reliably delivering plasmid DNA and look forward to bringing our therapies to patients.” – Jeremy Elser, Founding CEO, Ship of Theseus

Charles River to Perform Plasmid Production for Ship of Theseus

Retrieved on: 
Thursday, April 4, 2024
Health, Medical Devices, Stem Cells, Genetics, General Health, Pharmaceutical, Biotechnology, Diabetes, Neutropenia, CDMO, Psoriasis, Infertility, Cancer, MCB, Tissue, CRL, DNA, Research, Pattern hair loss, HOX, Ship, Acquisition, Factorization of polynomials, Display resolution, GMP, Good manufacturing practice, Tecmar, Therapy, HQ, Vaccine

Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) and Ship of Theseus , a therapeutics company developing degradation-resistant homeobox (HOX) family biologics, today announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement.
  • Ship of Theseus will leverage Charles River’s premier expertise to manufacture GMP plasmid DNA to serve as the active drug substance for its lead candidate.
  • Charles River’s GMP plasmid DNA CDMO center of excellence based in Keele, United Kingdom will lead the collaboration, providing services that include plasmid DNA backbone generation, plasmid synthesis, GMP master cell bank (MCB) generation, pre-production evaluation, and GMP plasmid DNA manufacture including in-house release testing.
  • We trust the team’s decades of success developing, producing, and reliably delivering plasmid DNA and look forward to bringing our therapies to patients.” – Jeremy Elser, Founding CEO, Ship of Theseus